Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delfarma is a leading Polish pharmaceutical company specializing in the parallel import of medicinal products within the European Economic Area. Established in 2004, the company focuses on providing cost-effective access to original branded medicines by sourcing them from markets with lower prices and distributing them in Poland. Beyond parallel trade, Delfarma provides specialized contract manufacturing services, including secondary packaging and labeling in compliance with Good Manufacturing Practice (GMP) standards. The company operates a sophisticated logistics and distribution infrastructure to serve a broad network of pharmacies and hospitals. As a key player in the Polish pharmaceutical supply chain, Delfarma contributes to healthcare sustainability by introducing price competition for high-demand medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delfarma.